1. Arslan, M.A., et al., Expanded biochemical analyses of human tear fluid: Polyvalent faces of the schirmer strip. Experimental eye research, 2023: p. 109679.
2. Kwon, J., et al., Overview of Dry Eye Disease for Primary Care Physicians. Medicina, 2025. 61.
3. Rękas, B., et al., Dry eye disease as a common ocular disorder – current knowledge and management. Journal of Education, Health and Sport, 2024.
4. Di Zazzo, A., et al., One Soul and Several Faces of Evaporative Dry Eye Disease. Journal of Clinical Medicine, 2024. 13.
5. Alkhaldi, S., et al., Estimates of dry eye disease in Saudi Arabia based on a short questionnaire of prevalence, symptoms, and risk factors: The Twaiq Mountain Eye Study I. Contact lens & anterior eye : the journal of the British Contact Lens Association, 2022: p. 101770.
6. Jareebi, M., et al., Exploring the Prevalence of Dry Eye Disease and Its Impact on Quality of Life in Saudi Adults: A Cross-Sectional Investigation. Medicina, 2025. 61.
7. Alrabghi, D., et al., Prevalence and Associated Risk Factors of Dry Eye Disease Among Children and Adults in Saudi Arabia: A Cross-Sectional Study. Cureus, 2023. 15.
8. Al-Dossary, S.K., Environmental and Occupational Triggers of Dry Eye Symptoms in the Ahsa Region of Saudi Arabia: A Cross-Sectional Study. Clinical Ophthalmology (Auckland, N.Z.), 2024. 18: p. 2427-2438.
9. Helayel, H., et al., Prevalence and Risk Factors of Dry Eye Disease among Adults in Saudi Arabia. Saudi Journal of Medicine & Medical Sciences, 2023. 11: p. 242-249.
10. Almutairi, A.H., et al., Prevalence of dry eye syndrome in association with the use of contact lenses in Saudi Arabia. BMC Ophthalmology, 2021. 21.
11. AlMarshedi, M. and S. Alshammari, The Prevalence of Dry Eye Disease and Related Factors Among Adult Patients Attending Primary Healthcare Centers in Riyadh, Saudi Arabia. Cureus, 2022. 14.
12. Alshamrani, A., et al., Prevalence and Risk Factors of Dry Eye Symptoms in a Saudi Arabian Population. Middle East African Journal of Ophthalmology, 2017. 24: p. 67-73.
13. Tananuvat, N., et al., Reliability, validity, and responsiveness of the Thai version of the Dry Eye-Related Quality-of-Life Score questionnaire. PLoS ONE, 2022. 17.
14. Akowuah, P., et al., Comparison of the performance of the dry eye questionnaire (DEQ-5) to the ocular surface disease index in a non-clinical population. Contact lens & anterior eye : the journal of the British Contact Lens Association, 2021: p. 101441.
15. Chatterjee, S., D. Agrawal, and P. Chaturvedi, Ocular Surface Disease Index© and the five-item dry eye questionnaire: A comparison in Indian patients with dry eye disease. Indian Journal of Ophthalmology, 2021. 69: p. 2396-2400.
16. Britten-Jones, A.C., et al., Epidemiology and Risk Factors of Dry Eye Disease: Considerations for Clinical Management. Medicina, 2024. 60.
17. Seen, S. and L. Tong, Dry eye disease and oxidative stress. Acta Ophthalmologica, 2018. 96.
18. Sheppard, J., B.S. Lee, and L. Periman, Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists. Annals of Medicine, 2022. 55: p. 241-252.
19. Gorimanipalli, B., et al., Hormones and dry eye disease. Indian Journal of Ophthalmology, 2023. 71: p. 1276-1284.
20. Wong, J. and A. Barak, Managing Dry Eye Disease with Novel Medications: Mechanism, Study Validity, Safety, Efficacy, and Practical Application. Pharmacy, 2024. 12.
21. Kitazawa, K., et al., Impact of aging on the pathophysiology of dry eye disease: A systematic review and meta-analysis. The ocular surface, 2022.
22. Binyousef, F., et al., Impact of Dry Eye Disease on Work Productivity Among Saudi Workers in Saudi Arabia. Clinical Ophthalmology (Auckland, N.Z.), 2021. 15: p. 2675-2681.
23. Abubaker, S.K., et al., Prevalence of dry eye disease among indoor and outdoor workers and the impact on work productivity in the West Bank of Palestine in 2024: a cross-sectional study. BMC Public Health, 2025. 25.
24. Boboridis, K., et al., Patient-reported burden and overall impact of dry eye disease across eight European countries: a cross-sectional web-based survey. BMJ Open, 2023. 13.
25. Cheong, N., et al., Symptomology and Impact of Dry Eye Disease: A Patient and Physician Perspective. Ophthalmology and Therapy, 2025. 14: p. 1357-1368.
26. Villani, E., et al., From Symptoms to Satisfaction: Optimizing Patient-Centered Care in Dry Eye Disease. Journal of Clinical Medicine, 2025. 14.
27. Cutrupi, F., et al., Real Life Impact of Dry Eye Disease. Seminars in Ophthalmology, 2023. 38: p. 690-702.
28. McDonald, M., et al., Economic and Humanistic Burden of Dry Eye Disease in Europe, North America, and Asia: A Systematic Literature Review. The ocular surface, 2016. 14 2: p. 144-167.
29. Kadiri, B., U. Vivekanand, and S.R. Lobo, Comparative analysis of Dry Eye Questionnaire 5 and Ocular Surface Disease Index in assessing dry eye symptoms. Journal of Clinical Ophthalmology and Research, 2024. 12(2): p. 130-132.
30. Chalmers, R.L., C.G. Begley, and B. Caffery, Validation of the 5-Item Dry Eye Questionnaire (DEQ-5): Discrimination across self-assessed severity and aqueous tear deficient dry eye diagnoses. Contact Lens and Anterior Eye, 2010. 33(2): p. 55-60.
31. Chalmers, R.L., et al., Contact Lens Dry Eye Questionnaire-8 (CLDEQ-8) and opinion of contact lens performance. Optom Vis Sci, 2012. 89(10): p. 1435-42.
32. Clevelandclinic. Diagnosis of dry eye. Available from: https://my.clevelandclinic.org/health/diseases/24479-dry-eye.
33. Wolffsohn, J.S., et al., TFOS DEWS II Diagnostic Methodology report. The Ocular Surface, 2017. 15(3): p. 539-574.
34. Golden, M.I., et al., Dry eye syndrome, in StatPearls [Internet]. 2024, StatPearls Publishing.
35. Bron, A.J., V.E. Evans, and J.A. Smith, Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea, 2003. 22(7): p. 640-50.
36. Optometrists.org, Dry eye diagnosis.
37. Craig, J.P., et al., TFOS DEWS II Report Executive Summary. The Ocular Surface, 2017. 15(4): p. 802-812.
38. Healthline. 20-20-20 rule. Available from: https://www.healthline.com/health/eye-health/20-20-20-rule.
39. Mayoclinic. Dry eye management. Available from: https://www.mayoclinic.org/diseases-conditions/dry-eyes/symptoms-causes/syc-20371863.
40. Jones, L., et al., TFOS DEWS II Management and Therapy Report. Ocul Surf, 2017. 15(3): p. 575-628.
41. Zhao, Y., et al., Clinical Trial of Thermal Pulsation (LipiFlow) in Meibomian Gland Dysfunction With Preteatment Meibography. Eye Contact Lens, 2016. 42(6): p. 339-346.
42. Optometrists.org. Can Warm Compresses Help Dry Eyes? ; Available from: https://www.optometrists.org/general-practice-optometry/guide-to-eye-conditions/dry-eye/natural-remedies-for-dry-eyes/can-warm-compresses-help-dry-eyes/#:~:text=Warm%20compresses%20provide%20a%20hydrating,or%20ointment%20for%20optimal%20results.
43. Lam, D., et al., Optimizing Diagnosis and Management of Dry Eye Disease: A Practical Framework for Hong Kong. Ophthalmol Ther, 2025. 14(5): p. 815-833.
44. Boekschoten, M.V., et al., Coffee oil consumption increases plasma levels of 7alpha-hydroxy-4-cholesten-3-one in humans. J Nutr, 2005. 135(4): p. 785-9.
45. Winnipegdryeye. The Role of Nutrition and Hydration in Managing Dry Eye. Available from: https://www.winnipegdryeye.com/the-role-of-nutrition-and-hydration-in-managing-dry-eye/.
46. Beyondvisioncenter. Nutrition for dry eye. Available from: https://www.beyondvisioncenter.com/diet-nutrition-dry-eyes/#:~:text=Processed%20foods%20often%20contain%20high,Provides%20potassium%20and%20natural%20sweetness.
47. Ervin, A.M., A. Law, and A.D. Pucker, Punctal occlusion for dry eye syndrome. Cochrane Database Syst Rev, 2017. 6(6): p. Cd006775.
48. Yim, T.W., et al., LipiFlow for the treatment of dry eye disease: A Cochrane systematic review summary. Cont Lens Anterior Eye, 2025. 48(2): p. 102335.
49. Daull, P., et al., Efficacy of a new topical cationic emulsion of cyclosporine A on dry eye clinical signs in an experimental mouse model of dry eye. Experimental Eye Research, 2016. 153: p. 159-164.
50. Sheppard, J.D., et al., Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study. Ophthalmology, 2014. 121(2): p. 475-83.
51. Sheppard, J.D., et al., Effect of loteprednol etabonate 0.5% on initiation of dry eye treatment with topical cyclosporine 0.05%. Eye Contact Lens, 2014. 40(5): p. 289-96.
52. Foulks, G.N., et al., Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction: a comparative clinical and spectroscopic pilot study. Cornea, 2013. 32(1): p. 44-53.
53. NHS. Dry eye management Available from: https://share.google/VkCzCZXFAbVFAav7O.
54. associate, E.c. Dry eye complications. Available from:
https://www.icareassociates.com/blog/what-are-the-potential-complications-of-untreated-dry-eye.
html#:~:text=Potential%20Complications%20of%20Untreated%20Dry%20Eye%20Syndrome,and%20distortion%20of%20the%20cornea).